Canada Pension Plan Investment Board’s AbCellera Biologics ABCL Stock Holding History

Canada Pension Plan Investment Board’s Portfolio ABCL Stock Details ABCL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-31,293	Closed	-$310K	–	1161
2022 Q3	$310K	Sell	31,293 -362,483	-92%	-$3.98M	﹤0.01%	1006
2022 Q2	$4.19M	Hold	393,776	–	–	0.01%	561
2022 Q1	$3.84M	Sell	393,776 -41,624	-10%	-$394K	0.01%	645
2021 Q4	$6.23M	Buy	+435,400	New	+$6.61M	0.01%	667
2021 Q2	–	Sell	-125,000	Closed	-$4.25M	–	1140
2021 Q1	$4.25M	Buy	+125,000	New	+$4.98M	0.01%	670

Other funds holding ABCL

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VOYA Investment Management Atlanta, Georgia $116B AUM 61.47% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

HMC

Harvard Management Company Boston, Massachusetts $4.26B AUM 5.81% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

FFVM

Founders Fund VII Management San Francisco, California $2.03M AUM 72.34% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Canada Pension Plan Investment Board's ABCL Position: Q4 2022 in Review

Canada Pension Plan Investment Board sold out of AbCellera Biologics (ABCL) in Q4 2022, closing a stake of 31,293 shares — an estimated $310K sold.

Canada Pension Plan Investment Board first reported a position in ABCL in Q1 2021 and held it in 5 quarters. The position peaked at $6.23M in Q4 2021. 201 funds tracked by Wall St. Rank hold ABCL as of Q4 2022.

Canada Pension Plan Investment Board reported no remaining AbCellera Biologics position as of Q4 2022 after selling out during the quarter.
Canada Pension Plan Investment Board sold 31,293 AbCellera Biologics shares in Q4 2022, an estimated $310K.
Canada Pension Plan Investment Board first reported a position in AbCellera Biologics in Q1 2021 and held it in 5 quarters.
Canada Pension Plan Investment Board's AbCellera Biologics position peaked at $6.23M in Q4 2021.
201 funds tracked by Wall St. Rank held AbCellera Biologics as of Q4 2022.

Based on Canada Pension Plan Investment Board's 13F filing for Q4 2022, filed 14 Feb 2023.